These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20356944)
1. Randomized controlled trial of mammographic screening from age 40 ('Age' trial): patterns of screening attendance. Johns LE; Moss SM; J Med Screen; 2010; 17(1):37-43. PubMed ID: 20356944 [TBL] [Abstract][Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657 [TBL] [Abstract][Full Text] [Related]
3. False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial). Johns LE; Moss SM; Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2758-64. PubMed ID: 20837718 [TBL] [Abstract][Full Text] [Related]
4. Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years. Moss S; Thomas I; Evans A; Thomas B; Johns L; Br J Cancer; 2005 Mar; 92(5):949-54. PubMed ID: 15726102 [TBL] [Abstract][Full Text] [Related]
5. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Moss SM; Cuckle H; Evans A; Johns L; Waller M; Bobrow L; Lancet; 2006 Dec; 368(9552):2053-60. PubMed ID: 17161727 [TBL] [Abstract][Full Text] [Related]
6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. Lynge E APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674 [TBL] [Abstract][Full Text] [Related]
7. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144 [TBL] [Abstract][Full Text] [Related]
8. Mammography screening in the county of Fyn. November 1993-December 1999. Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252 [TBL] [Abstract][Full Text] [Related]
9. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Duffy SW; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith RA; Evans A; Blyuss O; Johns L; Ellis IO; Myles J; Sasieni PD; Moss SM Lancet Oncol; 2020 Sep; 21(9):1165-1172. PubMed ID: 32800099 [TBL] [Abstract][Full Text] [Related]
10. A randomised trial of invitations to attend for screening mammography. Turnbull D; Irwig L; Adelson P Aust J Public Health; 1991 Mar; 15(1):33-6. PubMed ID: 2025672 [TBL] [Abstract][Full Text] [Related]
11. Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial. Allgood PC; Maroni R; Hudson S; Offman J; Turnbull AE; Peacock L; Steel J; Kirby G; Ingram CE; Somers J; Fuller C; Threlfall AG; Gabe R; Maxwell AJ; Patnick J; Duffy SW Lancet Oncol; 2017 Jul; 18(7):972-980. PubMed ID: 28522311 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892 [TBL] [Abstract][Full Text] [Related]
13. An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial. Acharya A; Darzi A; Judah G Lancet; 2023 Nov; 402 Suppl 1():S17. PubMed ID: 37997056 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands. van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083 [TBL] [Abstract][Full Text] [Related]
15. Predicting reattendance to the second round of the Maltese national breast screening programme: an analytical descriptive study. Marmarà D; Marmarà V; Hubbard G BMC Public Health; 2019 Feb; 19(1):189. PubMed ID: 30760275 [TBL] [Abstract][Full Text] [Related]
16. Assessing the resource implications of extending routine invitation to breast screening to women aged 65-67 years. van der Pol M; Cairns J Eur J Cancer; 2001 Sep; 37(14):1790-6. PubMed ID: 11549433 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening programme as setting for an adjunct research project: effect on programme attendance. Gram IT; Lund E J Med Screen; 2008; 15(1):44-5. PubMed ID: 18416955 [TBL] [Abstract][Full Text] [Related]
18. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501 [TBL] [Abstract][Full Text] [Related]
19. [Attendance in the Norwegian Breast Cancer Screening Programme]. Sebuødegård S; Sagstad S; Hofvind S Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204 [TBL] [Abstract][Full Text] [Related]
20. A randomised trial of general practitioner-written invitations to encourage attendance at screening mammography. Irwig L; Turnbull D; McMurchie M Community Health Stud; 1990; 14(4):357-64. PubMed ID: 2073774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]